Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

Clinical trial NCT01154387 · UNKNOWN

Trial details

NCT number: NCT01154387
Sponsor: Tolera Therapeutics, Inc
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

End Stage Renal Disease Renal Transplant

Start date: 2010-07-01
Primary completion: 2013-06-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.